p53 status and the efficacy of cancer therapy in vivo SW Lowe, S Bodis, A McClatchey, L Remington, HE Ruley, DE Fisher, ... Science 266 (5186), 807-810, 1994 | 2031 | 1994 |
Local hyperthermia combined with radiotherapy and-/or chemotherapy: Recent advances and promises for the future NR Datta, SG Ordóñez, US Gaipl, MM Paulides, H Crezee, J Gellermann, ... Cancer treatment reviews 41 (9), 742-753, 2015 | 590 | 2015 |
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma W Weder, RA Stahel, J Bernhard, S Bodis, P Vogt, P Ballabeni, ... Annals of oncology 18 (7), 1196-1202, 2007 | 414 | 2007 |
PKC412-a protein kinase inhibitor with a broad therapeutic potential D Fabbro, S Ruetz, S Bodis, M Pruschy, K Csermak, A Man, ... Anti-cancer drug design 15 (1), 17-28, 2000 | 384 | 2000 |
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma W Weder, P Kestenholz, C Taverna, S Bodis, D Lardinois, M Jerman, ... Journal of Clinical Oncology 22 (17), 3451-3457, 2004 | 313 | 2004 |
Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials. gov registry N Cihoric, A Tsikkinis, G van Rhoon, H Crezee, DM Aebersold, S Bodis, ... International journal of hyperthermia 31 (6), 609-614, 2015 | 271 | 2015 |
Radiation therapy infrastructure and human resources in low-and middle-income countries: present status and projections for 2020 NR Datta, M Samiei, S Bodis International Journal of Radiation Oncology* Biology* Physics 89 (3), 448-457, 2014 | 247 | 2014 |
Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth C Hess, V Vuong, I Hegyi, O Riesterer, J Wood, D Fabbro, C Glanzmann, ... British journal of cancer 85 (12), 2010-2016, 2001 | 220 | 2001 |
Hyperthermia and radiation therapy in locoregional recurrent breast cancers: a systematic review and meta-analysis NR Datta, E Puric, D Klingbiel, S Gomez, S Bodis International Journal of Radiation Oncology* Biology* Physics 94 (5), 1073-1087, 2016 | 219 | 2016 |
Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? C Ares, S Khan, AM MacArtain, J Heuberger, G Goitein, G Gruber, ... International Journal of Radiation Oncology* Biology* Physics 76 (3), 685-697, 2010 | 184 | 2010 |
Hyperthermia and radiotherapy in the management of head and neck cancers: A systematic review and meta-analysis NR Datta, S Rogers, SG Ordóñez, E Puric, S Bodis International Journal of Hyperthermia 32 (1), 31-40, 2016 | 161 | 2016 |
Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: a systematic review and meta-analysis NR Datta, E Stutz, M Liu, S Rogers, D Klingbiel, A Siebenhüner, S Singh, ... Gynecologic oncology 145 (2), 374-385, 2017 | 156 | 2017 |
Acute toxicity and quality of life after dose-intensified salvage radiation therapy for biochemically recurrent prostate cancer after prostatectomy: first results of the … P Ghadjar, S Hayoz, J Bernhard, DR Zwahlen, T Hölscher, P Gut, ... Journal of clinical oncology 33 (35), 4158-4166, 2015 | 126 | 2015 |
Effect of high dose per pulse flattening filter-free beams on cancer cell survival I Lohse, S Lang, J Hrbacek, S Scheidegger, S Bodis, NS Macedo, J Feng, ... Radiotherapy and Oncology 101 (1), 226-232, 2011 | 123 | 2011 |
Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease. S Bodis, MD Kraus, G Pinkus, B Silver, ME Kadin, GP Canellos, ... Journal of clinical oncology 15 (9), 3060-3066, 1997 | 120 | 1997 |
Hyperthermia and radiotherapy with or without chemotherapy in locally advanced cervical cancer: a systematic review with conventional and network meta-analyses NR Datta, S Rogers, D Klingbiel, S Gómez, E Puric, S Bodis International Journal of Hyperthermia 32 (7), 809-821, 2016 | 110 | 2016 |
Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib … GA Pesce, D Klingbiel, K Ribi, A Zouhair, R Von Moos, M Schlaeppi, ... European Journal of Cancer 48 (3), 377-384, 2012 | 110 | 2012 |
Magnetic nanoparticle-induced hyperthermia with appropriate payloads: Paul Ehrlich’s “magic (nano) bullet” for cancer theranostics? NR Datta, S Krishnan, DE Speiser, E Neufeld, N Kuster, S Bodis, ... Cancer treatment reviews 50, 217-227, 2016 | 98 | 2016 |
The phosphatidylinositide 3′-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C A Tenzer, D Zingg, S Rocha, B Hemmings, D Fabbro, C Glanzmann, ... Cancer research 61 (22), 8203-8210, 2001 | 97 | 2001 |
Degradation of PKB/Akt protein by inhibition of the VEGF receptor/mTOR pathway in endothelial cells O Riesterer, D Zingg, J Hummerjohann, S Bodis, M Pruschy Oncogene 23 (26), 4624-4635, 2004 | 94 | 2004 |